| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.091 | 0.002 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.002 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.091 | 0.002 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.002 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.003 |